Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2011)
- Authors:
- USP affiliated authors: MENDONÇA, BERENICE BILHARINHO DE - FM ; BACHEGA, TÂNIA APARECIDA SARTORI SANCHEZ - FM ; JORGE, ALEXANDER AUGUSTO DE LIMA - FM
- Unidade: FM
- DOI: 10.1590/S1807-59322011000800009
- Subjects: FARMACOGENÉTICA; HIPERPLASIA SUPRARRENAL CONGÊNITA; HIDROXILASE (DEFICIÊNCIA)
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
MOREIRA, Ricardo P. P. et al. Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clinics, v. 66, n. 8, p. 1361-1365, 2011Tradução . . Disponível em: https://doi.org/10.1590/S1807-59322011000800009. Acesso em: 05 maio 2024. -
APA
Moreira, R. P. P., Jorge, A. A. L., Gomes, L. G., Kaupert, L. C., Massud Filho, J., Mendonca, B. B., & Bachega, T. A. S. S. (2011). Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clinics, 66( 8), 1361-1365. doi:10.1590/S1807-59322011000800009 -
NLM
Moreira RPP, Jorge AAL, Gomes LG, Kaupert LC, Massud Filho J, Mendonca BB, Bachega TASS. Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency [Internet]. Clinics. 2011 ; 66( 8): 1361-1365.[citado 2024 maio 05 ] Available from: https://doi.org/10.1590/S1807-59322011000800009 -
Vancouver
Moreira RPP, Jorge AAL, Gomes LG, Kaupert LC, Massud Filho J, Mendonca BB, Bachega TASS. Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency [Internet]. Clinics. 2011 ; 66( 8): 1361-1365.[citado 2024 maio 05 ] Available from: https://doi.org/10.1590/S1807-59322011000800009 - Frequency of genetic polymorphisms of PXR gene in the Brazilian population
- The effect of fetal androgen metabolism-related gene variants on external genitalia virilization in congenital adrenal hyperplasia
- Growth hormone deficiency with advanced bone age: phenotypic interaction between GHRH receptor and CYP21A2 mutations diagnosed by sanger and whole exome sequencing
- Síndromes hiperandrogênicas
- Classic congenital adrenal hyperplasia and its impact on reproduction
- Quality of life in a large cohort of adult Brazilian patients with 46,XX and 46,XY disorders of sex development from a single tertiary centre
- Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia
- Modulatory effect of BclI GR gene polymorphisms on the obesity phenotype in Brazilian patients with Cushing's disease
- Gender identity and sexual orientation in adult patients with classical virilizing congenital adrenal hyperplasia (CAH)
- Overexpression of 5 alfa-reductase type 2 in genital skin contributes to higher degree of external genitalia virilization in CAH females
Informações sobre o DOI: 10.1590/S1807-59322011000800009 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
